BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 15668521)

  • 1. Pharmacogenomics and systems biology of membrane transporters.
    Yan Q
    Mol Biotechnol; 2005 Jan; 29(1):75-88. PubMed ID: 15668521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane transporters and drug development: relevance to pharmacogenomics, nutrigenomics, epigenetics, and systems biology.
    Yan Q
    Methods Mol Biol; 2010; 637():1-21. PubMed ID: 20419427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics for transporter pharmacogenomics and systems biology: data integration and modeling with UML.
    Yan Q
    Methods Mol Biol; 2010; 637():23-45. PubMed ID: 20419428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacogenomics of membrane transporters project: research at the interface of genomics and transporter pharmacology.
    Kroetz DL; Yee SW; Giacomini KM
    Clin Pharmacol Ther; 2010 Jan; 87(1):109-16. PubMed ID: 19940846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The integration of personalized and systems medicine: bioinformatics support for pharmacogenomics and drug discovery.
    Yan Q
    Methods Mol Biol; 2008; 448():1-19. PubMed ID: 18370227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Drug Transporters in Organ Toxicity: The Fundamental Basis of Drug Discovery and Development.
    Cheng Y; El-Kattan A; Zhang Y; Ray AS; Lai Y
    Chem Res Toxicol; 2016 Apr; 29(4):545-63. PubMed ID: 26889774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Personalized dosing from perspective of pharmacogenomics of drug metabolizing enzymes and transporters].
    Zhou Q; Yu LS; Zeng S
    Yao Xue Xue Bao; 2017 Jan; 52(1):1-7. PubMed ID: 29911367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of membrane transporters: a review of current approaches.
    Sissung TM; Goey AK; Ley AM; Strope JD; Figg WD
    Methods Mol Biol; 2014; 1175():91-120. PubMed ID: 25150868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers.
    Lima A; Sousa H; Monteiro J; Azevedo R; Medeiros R; Seabra V
    Pharmacogenomics; 2014; 15(12):1611-35. PubMed ID: 25340735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.
    Lai Y; Varma M; Feng B; Stephens JC; Kimoto E; El-Kattan A; Ichikawa K; Kikkawa H; Ono C; Suzuki A; Suzuki M; Yamamoto Y; Tremaine L
    Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):723-43. PubMed ID: 22509796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Institutional Profile: The University of California Pharmacogenomics Center: at the interface of genomics, biological mechanisms and drug therapy.
    Kroetz DL; Ahituv N; Burchard EG; Guo S; Sali A; Giacomini KM
    Pharmacogenomics; 2009 Oct; 10(10):1569-76. PubMed ID: 19842929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.
    Yee SW; Brackman DJ; Ennis EA; Sugiyama Y; Kamdem LK; Blanchard R; Galetin A; Zhang L; Giacomini KM
    Clin Pharmacol Ther; 2018 Nov; 104(5):803-817. PubMed ID: 29679469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized pharmacogenomics profiling using whole-genome sequencing.
    Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
    Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to Reduce Solute Carrier-Mediated Toxicity.
    Hu S; Sprowl JA
    Clin Pharmacol Ther; 2018 Nov; 104(5):799-802. PubMed ID: 30028006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.
    Ahmed S; Zhou Z; Zhou J; Chen SQ
    Genomics Proteomics Bioinformatics; 2016 Oct; 14(5):298-313. PubMed ID: 27729266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it.
    Kell DB
    FEBS J; 2013 Dec; 280(23):5957-80. PubMed ID: 23552054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane transporters in drug development.
    Keogh JP
    Adv Pharmacol; 2012; 63():1-42. PubMed ID: 22776638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology.
    Nigam SK; Bush KT; Bhatnagar V; Poloyac SM; Momper JD
    Clin Pharmacol Ther; 2020 Jul; 108(1):40-53. PubMed ID: 32119114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics of membrane transporters: past, present and future.
    Yee SW; Chen L; Giacomini KM
    Pharmacogenomics; 2010 Apr; 11(4):475-9. PubMed ID: 20350125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective.
    Schlessinger A; Welch MA; van Vlijmen H; Korzekwa K; Swaan PW; Matsson P
    Clin Pharmacol Ther; 2018 Nov; 104(5):818-835. PubMed ID: 29981151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.